Result of GM, Major New Shareholder and TVR

Summary by AI BETAClose X

EnSilica plc announced that all resolutions were passed at its general meeting, allowing the Second Tranche Placing and Retail Offer to proceed, with new Ordinary Shares expected to commence trading on AIM on April 8, 2026. Esterhuyzen Limited will become a substantial shareholder, increasing its stake to 13.57% of the enlarged issued share capital. Following the fundraising, significant shareholders Ian Lankshear, Richard Ashley Hamer, Marc Castells, Richard Neil Marley, Alan Chi Wai Wong, and Andrew Peter Maund will experience dilution, with their post-admission percentages being 13.61%, 4.97%, 4.88%, 4.05%, 2.88%, and 2.81% respectively. Upon admission, the total voting rights in the company will be 117,877,230.

Disclaimer*

EnSilica PLC
07 April 2026
 

7 April 2026

NEWS RELEASE

A blue and black text AI-generated content may be incorrect.

("EnSilica", the "Company" or the "Group")

 

Result of General Meeting, Welcome to New Substantial Shareholder & Total Voting Rights

 

EnSilica plc (AIM: ENSI), a leading fabless, application-specific chipmaker, announces that at the general meeting of the Company held earlier today, all resolutions were duly passed. The results of the proxy voting will be available on the Company's website in due course.

 

As a result of the resolutions being passed today, the Second Tranche Placing and the Retail Offer as announced on 13 March 2026 and 18 March 2026 can now proceed to completion. It is expected that Admission will become effective and dealings in the new Ordinary Shares will commence on AIM at 8.00 a.m. on 8 April 2026.

 

Welcome to new substantial shareholder

 

The board of directors of EnSilica looks forward to welcoming Esterhuyzen Limited ("Esterhuyzen") as a substantial shareholder following Esterhuyzen's participation in the Second Tranche Placing. Esterhuyzen participated in the First Tranche Placing and, as announced on 19 March 2026, currently holds 8,000,000 Ordinary Shares, representing 7.53 per cent. of the Company's current issued share capital. Following Esterhuyzen's participation in the Second Tranche Placing, Esterhuyzen is expected to hold 16,000,000 Ordinary Shares, representing 13.57 per cent. of the enlarged issued share capital from Admission.

 

Esterhuyzen Limited is a privately held family office investment holding company with a particular focus on the pan European semiconductor sector. Esterhuyzen Limited's investment approach is long-term, and they are supportive of the Company's existing strategic direction.

 

Changes to significant shareholdings in the Company

 

With the completion of the Fundraising, the Company is aware of dilution to the following significant shareholders in the Company whose percentage interests on Admission is expected to be as follows:

 

Name

Total number of Ordinary Shares held

Percentage of issued share capital held on Admission

Ian Lankshear

                      16,040,358

13.61%

Richard Ashley Hamer

            5,857,490

4.97%

Marc Castells

               5,746,554

4.88%

Richard Neil Marley

             4,771,554

4.05%

Alan Chi Wai Wong

                   3,400,000

2.88%

Andrew Peter Maund

                     3,310,237

2.81%

 

 

Total Voting Rights

 

Upon Admission, the Company's issued share capital will consist of 117,877,230 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 117,877,230. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 4:35 p.m. on 12 March 2026.

 

 

EnSilica plc

Ian Lankshear, Chief Executive Officer

Kristoff Rademan, Chief Financial Officer

www.ensilica.com

via Novella Communications

+44 (0)20 3151 7008  

 

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

Jeremy Porter / Vivek Bhardwaj (Corporate Finance)

Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking)

 

 

+44 (0)20 3328 5656

info@allenbycapital.com



Panmure Liberum Limited (Joint Broker)

Edward Mansfield / Will King / Phoebe Bunce

 

+44 (0)20 3100 2000

 

 

 

Novella Communications (Investor & Financial Public Relations)

Tim Robertson / Aeliya Bilgrami

 

+44 (0)20 3151 7008  

ensilica@novella-comms.com

 

 

 

About EnSilica plc

EnSilica is a fabless, application-specific chipmaker, combining deep domain and system-level expertise with world-class capability in RF, mmWave, mixed-signal and complex digital IC design. The Company serves customers across the space and communications, industrial, automotive and healthcare markets, where safety and security and reliability are critical.

A growing portfolio of reusable IP and silicon platforms underpins a repeatable, scalable delivery model, reducing development risk, cost and time to market while supporting long-term supply revenues. EnSilica has a strong track record of delivering production-proven silicon to demanding industry standards. Headquartered near Oxford, UK, the Company operates design centres across the UK, India, Brazil and Hungary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

EnSilica (ENSI)
UK 100

Latest directors dealings